![]() |
![]() |
|
|
Vibrant® Soundbridge®Overview(All photos courtesy of MedEl Corporation) OverviewThe Vibrant® Soundbridge® is an FDA approved, direct-drive, semi-implantable middle ear device intended to provide a level of useful sound perception to individuals with a moderate-to-severe sensorineural hearing loss. The Soundbridge converts sound into mechanical energy that is directly transferred to the middle ear bone (auditory ossicles). Direct-drive means that the implant attaches directly to the incus The Vibrant® Soundbridge® is considered a semi-implantable device because there is both an internal (implanted) component and an outer or external component. The internal component consists of two parts. The internal component placed directly under the skin behind the ear is known as the Vibrating Ossicular Prosthesis™ (VORP™). The second portion of the internal component is the Floating Mass Transducer™ (FMT™). The FMT™ attaches to the incus and vibrates the stapes bone. (See photo below)
The outer or external component is known as the Audio Processor. The AdvantagesA direct drive system provides mechanical energy directly to the ossicles, bypassing the ear canal and the tympanic membrane. The Floating Mass Transducer™ of the Soundbridge mechanically stimulates the ossicles, mimicking the natural hearing process. This eliminates many of the inherent issues of conventional hearing aids such as occlusion, feedback, discomfort, and the need for ear wax-related repairs. It also provides a measurable improvement in sound quality and clarity. Many patients also report improvement in noisy environments compared to conventional hearing aids.
Patient Selection
Examples of realistic expectations:
Overview of Surgical Procedure and Postoperative CareThe internal device is surgically implanted during an outpatient (same day) surgical procedure. The procedure is conducted under general anesthesia and takes 1 1/2 to 2 hours to complete. The VORP™ is implanted under the skin in back of the ear, and the FMT™ is attached to the long process of the incus during the procedure. The middle ear structures are not modified. Therefore, there is no significant impact on the residual hearing of the patient. The risks of surgery are similar to that of routine ear surgery. After a few days rest, the patient can resume normal activities. Eight weeks after the procedure, the patient is fitted with the external Vibrant® Soundbridge® Photos
|
|||||||||||||||||||||||||||||
© 2007 Ear Institute
of Chicago, LLC |
||||||||||||||||||||||||||||||